LLY
733.87
+2.71%↑
JNJ
149.53
+2.14%↑
UNH
273.23
-11.3%↓
ABBV
181.65
+2.56%↑
NVO
66.05
+2.69%↑
LLY
733.87
+2.71%↑
JNJ
149.53
+2.14%↑
UNH
273.23
-11.3%↓
ABBV
181.65
+2.56%↑
NVO
66.05
+2.69%↑
LLY
733.87
+2.71%↑
JNJ
149.53
+2.14%↑
UNH
273.23
-11.3%↓
ABBV
181.65
+2.56%↑
NVO
66.05
+2.69%↑
LLY
733.87
+2.71%↑
JNJ
149.53
+2.14%↑
UNH
273.23
-11.3%↓
ABBV
181.65
+2.56%↑
NVO
66.05
+2.69%↑
LLY
733.87
+2.71%↑
JNJ
149.53
+2.14%↑
UNH
273.23
-11.3%↓
ABBV
181.65
+2.56%↑
NVO
66.05
+2.69%↑
24h
Actual
Mínimo
1.66
Máximo
1.77
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +798.88% upside |
Próximas Ganancias | 11 ago 2025 |
---|
El rendimiento pasado no es un indicador fiable de resultados futuros.
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 16 USD 798.88%
Máximo 16 USD
Mínimo 16 USD
De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
1 ratings
1
Comprar
0
Mantener
0
Vender
De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$